UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25
NOTIFICATION OF LATE FILING
 
SEC FILE NUMBER:  333-143626

CUSIP NUMBER:  02554E-30-3

(Check One):              [  ] Form 10-K [  ] Form 20-F [  ] Form 11-K [X] Form 10-Q [  ] Form 10-D [  ] Form N-SAR [  ] Form N-CSR
 
For Period Ended:  March 31, 2011
 
[  ] Transition Report on Form 10-K
[  ] Transition Report on Form 20-F
[  ] Transition Report on Form 11-K
[  ] Transition Report on Form 10-Q
[  ] Transition Report on Form N-SAR
For the Transition Period Ended:                                                             
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

AMERICAN EAGLE ENERGY INC.    

Full Name of Registrant
 
 

Former Name if Applicable
 
27 North 27 th Street, Suite 21G  

  Address of Principal Executive Office ( Street a nd Number )

Billings, MT  59101  

  City, State and Zip Code

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate): [X]

 
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
 
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
 
 
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
 

 
 
PART III – NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed period.
 
The Report on Form 10-Q for the period ended March 31, 2011 could not be filed without unreasonable effort or expense within the prescribed period due to the pending merger transaction with Eternal Energy Corp. and related disclosure requirements.  As a result, our internal accounting staff and outside independent auditors required additional time to conclude their preparation and review, respectively, of our financial statements and notes thereto for the current period.
 
PART IV – OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this notification:

Richard Findley
 
 (406)
 
 294-9765
(Name)
 
(Area Code)
 
  (Telephone Number)

(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If the answer is no, identify report(s). [X] Yes  [  ] No

(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [  ] Yes  [X] No
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 


     AMERICAN EAGLE ENERGY INC.     
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

       
Date: May 16, 2011
By:
 /S/ RICHARD FINDLEY  
   
Richard Findley
 
   
President and Chief Executive Officer
 
       

 
 
 

 
                                                          
Immage Biotherapeutics (CE) (USOTC:IMMG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Immage Biotherapeutics (CE) Charts.
Immage Biotherapeutics (CE) (USOTC:IMMG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Immage Biotherapeutics (CE) Charts.